Crossmark

Targeted treatment for neuroblastoma using methoxyestradiol (2-ME)-loaded mitochondria-targeting immunoliposomes modified by datuximab (anti-GD2) and (L-cyclohexyl alanine-D-arginine)3 ((Fx,r)3) peptide

Crossref DOI link: https://doi.org/10.1186/s12645-025-00335-0

Published Online: 2025-06-23

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wan, Mingyu

Chen, Zhili

Deng, Yueyi

Lee, Robert J.

Yan, Chengyun
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (22165006)

Guangxi Provincial Natural Science Foundation of China (2022GXNSFDA035085)
License Information

Text and Data Mining valid from 2025-06-23

Version of Record valid from 2025-06-23
More Information

Article History

Received: 31 December 2024

Accepted: 14 June 2025

First Online: 23 June 2025

Declarations

:

: The operation of all animal experiments adhered to the rules of the Ethics Committee for Animal Experiments at Guilin Medical University (ethics clearance number: GLMC202003039).

: Publication was approved by every author.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below